Annual EBIT
-$64.53 M
+$18.41 M+22.20%
31 December 2023
Summary:
Applied Therapeutics annual earnings before interest & taxes is currently -$64.53 million, with the most recent change of +$18.41 million (+22.20%) on 31 December 2023. During the last 3 years, it has risen by +$29.93 million (+31.68%). APLT annual EBIT is now -1406.07% below its all-time high of -$4.29 million, reached on 31 December 2017.APLT EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly EBIT
-$29.74 M
-$9.30 M-45.51%
30 September 2024
Summary:
Applied Therapeutics quarterly earnings before interest & taxes is currently -$29.74 million, with the most recent change of -$9.30 million (-45.51%) on 30 September 2024. Over the past year, it has dropped by -$14.25 million (-91.95%). APLT quarterly EBIT is now -1492.24% below its all-time high of -$1.87 million, reached on 31 March 2018.APLT Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM EBIT
-$92.28 M
-$14.25 M-18.26%
30 September 2024
Summary:
Applied Therapeutics TTM earnings before interest & taxes is currently -$92.28 million, with the most recent change of -$14.25 million (-18.26%) on 30 September 2024. Over the past year, it has dropped by -$29.78 million (-47.65%). APLT TTM EBIT is now -4840.26% below its all-time high of -$1.87 million, reached on 31 March 2018.APLT TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
APLT EBIT Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +22.2% | -92.0% | -47.6% |
| 3 y3 years | +31.7% | -4.6% | +9.8% |
| 5 y5 years | -377.4% | -176.8% | -172.2% |
APLT EBIT High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +38.9% | -173.9% | at low | -47.6% | +12.6% |
| 5 y | 5 years | -377.4% | +38.9% | -176.8% | +0.7% | -172.2% | +13.1% |
| alltime | all time | -1406.1% | +38.9% | -1492.2% | +0.7% | -4840.3% | +13.1% |
Applied Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$29.74 M(+45.5%) | -$92.28 M(+18.3%) |
| June 2024 | - | -$20.44 M(-3.1%) | -$78.04 M(+4.4%) |
| Mar 2024 | - | -$21.09 M(+0.4%) | -$74.77 M(+15.9%) |
| Dec 2023 | -$64.53 M(-22.2%) | -$21.01 M(+35.6%) | -$64.54 M(+3.3%) |
| Sept 2023 | - | -$15.49 M(-9.8%) | -$62.50 M(-5.8%) |
| June 2023 | - | -$17.18 M(+58.2%) | -$66.36 M(-6.1%) |
| Mar 2023 | - | -$10.86 M(-42.8%) | -$70.71 M(-14.8%) |
| Dec 2022 | -$82.95 M(-21.5%) | -$18.97 M(-2.0%) | -$82.95 M(-8.9%) |
| Sept 2022 | - | -$19.36 M(-10.1%) | -$91.09 M(-9.1%) |
| June 2022 | - | -$21.52 M(-6.8%) | -$100.17 M(-4.2%) |
| Mar 2022 | - | -$23.10 M(-14.8%) | -$104.52 M(-1.0%) |
| Dec 2021 | -$105.62 M | -$27.11 M(-4.6%) | -$105.62 M(+3.3%) |
| Sept 2021 | - | -$28.43 M(+9.9%) | -$102.25 M(-1.5%) |
| June 2021 | - | -$25.88 M(+6.9%) | -$103.79 M(-2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$24.20 M(+1.9%) | -$106.19 M(+12.4%) |
| Dec 2020 | -$94.47 M(+107.2%) | -$23.75 M(-20.8%) | -$94.46 M(+6.9%) |
| Sept 2020 | - | -$29.96 M(+6.0%) | -$88.38 M(+27.8%) |
| June 2020 | - | -$28.28 M(+126.8%) | -$69.16 M(+40.2%) |
| Mar 2020 | - | -$12.47 M(-29.4%) | -$49.32 M(+8.2%) |
| Dec 2019 | -$45.58 M(+237.2%) | -$17.67 M(+64.4%) | -$45.58 M(+34.5%) |
| Sept 2019 | - | -$10.75 M(+27.4%) | -$33.90 M(+28.0%) |
| June 2019 | - | -$8.44 M(-3.3%) | -$26.48 M(+29.9%) |
| Mar 2019 | - | -$8.73 M(+45.8%) | -$20.38 M(+50.8%) |
| Dec 2018 | -$13.52 M(+215.5%) | -$5.99 M(+80.2%) | -$13.52 M(+79.5%) |
| Sept 2018 | - | -$3.32 M(+42.2%) | -$7.53 M(+79.0%) |
| June 2018 | - | -$2.34 M(+25.1%) | -$4.21 M(+125.1%) |
| Mar 2018 | - | -$1.87 M | -$1.87 M |
| Dec 2017 | -$4.29 M | - | - |
FAQ
- What is Applied Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Applied Therapeutics?
- What is Applied Therapeutics annual EBIT year-on-year change?
- What is Applied Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Applied Therapeutics?
- What is Applied Therapeutics quarterly EBIT year-on-year change?
- What is Applied Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Applied Therapeutics?
- What is Applied Therapeutics TTM EBIT year-on-year change?
What is Applied Therapeutics annual earnings before interest & taxes?
The current annual EBIT of APLT is -$64.53 M
What is the all time high annual EBIT for Applied Therapeutics?
Applied Therapeutics all-time high annual earnings before interest & taxes is -$4.29 M
What is Applied Therapeutics annual EBIT year-on-year change?
Over the past year, APLT annual earnings before interest & taxes has changed by +$18.41 M (+22.20%)
What is Applied Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of APLT is -$29.74 M
What is the all time high quarterly EBIT for Applied Therapeutics?
Applied Therapeutics all-time high quarterly earnings before interest & taxes is -$1.87 M
What is Applied Therapeutics quarterly EBIT year-on-year change?
Over the past year, APLT quarterly earnings before interest & taxes has changed by -$14.25 M (-91.95%)
What is Applied Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of APLT is -$92.28 M
What is the all time high TTM EBIT for Applied Therapeutics?
Applied Therapeutics all-time high TTM earnings before interest & taxes is -$1.87 M
What is Applied Therapeutics TTM EBIT year-on-year change?
Over the past year, APLT TTM earnings before interest & taxes has changed by -$29.78 M (-47.65%)